z-logo
Premium
Epidermal growth factor receptors in spontaneous ovarian granulosa cell tumors of swr‐derived mice
Author(s) -
Tennent Barbara J.,
Beamer Wesley G.,
Shultz Leonard D.,
Adamson Eileen D.
Publication year - 1989
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910440317
Subject(s) - epidermal growth factor , receptor , biology , endocrinology , medicine , growth factor , ovarian tumor , polyclonal antibodies , cell growth , antibody , ovarian cancer , immunology , cancer , biochemistry
Epidermal growth factor (EGF) receptor binding properties were examined in spontaneous ovarian granulosa cell (GC) tumors from SWR and SWR‐derived strains of mice. EGF binding was measured at room temperature in tissue ho‐mogenates from GC tumors and normal ovaries from adult randomly cycling mice. GC tumor tissue displayed significantly increased EGF binding and 2 receptor populations (Rl and R2). Normal ovarian tissue appeared to have only one receptor population with a dissociation constant (K d ) similar to the Rl (high‐affinity) receptor in GC tumors. In subsequent experiments, GC tumor and normal granulosa cells from immature mice were analyzed in primary cultures for EGF binding, immunofluorescence microscopy for receptors, and cell proliferation. After 24 hr in culture, the GC tumors bound 10‐fold more EGF/ug protein than did normal granulosa cells. GC tumor cells, but not normal granulosa cells, showed specific immunofluorescence when reacted with a polyclonal antibody to mouse EGFR. During 96 hr in culture, GC tumor cells, but not normal cells, showed a significant proliferative response to EGF. In conclusion, the EGF binding capacity is markedly increased in GC tumor cells and the proliferation data suggest that this growth factor supports tumor growth in the SWR model system.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here